My non-medical understanding of erectile disfunction "ED" is that it exists on a spectrum depending on age and health etc. All males lie somewhere on this spectrum, thus why the issue interests so many.
There are many treatments both off and over the counter.
The leading so called "gold standard treatments" are known as "PDE5 inhibitors" which come in pill form.
Spontan is not a new drug, it is taking one of these widely used "PDE inhibitor" drugs, Vardenafil, and putting it into a more effective nasal spray form.
Vardenafil is "an existing and approved drug already in global markets since 2003".
Thus all testing and approvals for Vardenafil are relevant to Spontan, which is why approval process can be fast tracked.
Pfizers "Viagra" was the first of these "PDE5 inhibitor" pills and is the most popular, even though it is not the most effective (Avanafil pill is better).
This shows first mover advantage matters.
And Spontan has a first mover advantage in the superior nasal spray form of these treatments.
- Forums
- ASX - By Stock
- LTP
- Ann: SPONTAN achieves positive clinical study results
Ann: SPONTAN achieves positive clinical study results, page-178
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTP (ASX) to my watchlist
|
|||||
Last
78.0¢ |
Change
-0.010(1.27%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
80.0¢ | 81.0¢ | 75.0¢ | $296.4K | 380.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.5¢ | 2873 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 800 | 0.770 |
1 | 200 | 0.765 |
5 | 161314 | 0.760 |
2 | 20000 | 0.750 |
1 | 6690 | 0.745 |
Price($) | Vol. | No. |
---|---|---|
0.785 | 2873 | 1 |
0.790 | 2000 | 1 |
0.795 | 1234 | 1 |
0.800 | 10000 | 1 |
0.810 | 16915 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online